###begin article-title 0
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 8 11 8 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 11 15 11 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</italic>
###xml 11 15 11 15 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip2</italic></sup>
###xml 91 96 <span type="species:ncbi:10090">mouse</span>
Cdkn1c (p57Kip2) is the major regulator of embryonic growth within its imprinted domain on mouse distal chromosome 7
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 283 288 <span type="species:ncbi:10090">mouse</span>
###xml 390 395 <span type="species:ncbi:10090">mouse</span>
Cdkn1c encodes an embryonic cyclin-dependant kinase inhibitor that acts to negatively regulate cell proliferation and, in some tissues, to actively direct differentiation. This gene, which is an imprinted gene expressed only from the maternal allele, lies within a complex region on mouse distal chromosome 7, called the IC2 domain, which contains several other imprinted genes. Studies on mouse embryos suggest a key role for genomic imprinting in regulating embryonic growth and this has led to the proposal that imprinting evolved as a consequence of the mismatched contribution of parental resources in mammals.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 159 166 159 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 303 310 303 310 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 508 512 508 512 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1</italic>
###xml 548 555 548 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 625 629 625 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1</italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
In this study, we characterised the phenotype of mice carrying different copy number integrations of a bacterial artificial chromosome spanning Cdkn1c. Excess Cdkn1c resulted in embryonic growth retardation that was dosage-dependent and also responsive to the genetic background. Two-fold expression of Cdkn1c in a subset of tissues caused a 10-30% reduction in embryonic weight, embryonic lethality and was associated with a reduction in the expression of the potent, non-imprinted embryonic growth factor, Igf1. Conversely, loss of expression of Cdkn1c resulted in embryos that were 11% heavier with a two-fold increase in Igf1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
###xml 94 100 94 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 102 109 102 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 344 351 344 351 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 419 426 419 426 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 39 43 <span type="species:ncbi:10090">mice</span>
We have shown that embryonic growth in mice is exquisitely sensitive to the precise dosage of Cdkn1c. Cdkn1c is a maternally expressed gene and our findings support the prediction of the parental conflict hypothesis that that the paternal genome silences genes that have an inhibitory role in embryonic growth. Within the IC2 imprinted domain, Cdkn1c encodes the major regulator of embryonic growth and we propose that Cdkn1c was the focal point of the selective pressure for imprinting of this domain.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 261 262 261 262 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 554 555 554 555 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 556 557 556 557 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1062 1063 1062 1063 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 472 476 <span type="species:ncbi:10090">mice</span>
###xml 725 729 <span type="species:ncbi:10090">mice</span>
Genomic imprinting is an unusual epigenetic phenomenon that results in the absence of expression of one copy of an autosomal gene. This allele-specific expression is initiated by events that take place within the male and female germ line during gametogenesis [1]. The parental alleles acquire an epigenetic signature that is recognised in the somatic cell and, as a result, there is permanent and heritable silencing of one parental allele. Studies on imprinted genes in mice suggest a general role for imprinting in the regulation of embryonic growth [2-8]. Two key genes that regulate embryonic growth, insulin-like growth factor 2 (Igf2) and insulin-like growth factor receptor 2 (M6P/Igf2r) are oppositely imprinted. In mice, insulin-like growth factor 1 (Igf1) and the imprinted Igf2 are thought to be the two major growth signalling molecules. These factors work in combination with at least three receptors, the insulin receptor (Insr), insulin-like growth factor receptor 1 (Igf1r) and the imprinted Igf2r to exert local and systemic effects on growth [3].
###end p 9
###begin p 10
###xml 185 186 185 186 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 187 189 187 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
###xml 505 507 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 508 510 508 510 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 1152 1154 1152 1154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 1237 1238 1237 1238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 1239 1240 1239 1240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1241 1243 1241 1243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 1244 1246 1244 1246 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 144 149 <span type="species:ncbi:9606">human</span>
Single genetic or epigenetic changes can deregulate the function of an imprinted gene and they are particularly vulnerable targets for numerous human pathologies (recently reviewed in [9-11]. Since the cost of adopting monoallellic gene expression to an individual is clearly quite high, there must be a compelling reason for mammals to imprint their genes. The most widely accepted model that has been proposed to explain the evolution of genomic imprinting is known as the parental conflict hypothesis [12,13]. This hypothesis focuses on the asymmetry in mammals between parental contributions to the developing fetus. Although larger offspring are thought to be of benefit to both parents, in females there must be a balance between the fitness of the offspring and survival of the mother. Genomic imprinting of the paternal genome may have evolved to promote growth of the fetus while imprinting of the female genome occurred to counteract the effects of the paternal genome in order for the mother to survive and produce more offspring. However, deficiency in expression of an imprinted gene does not always lead to an embryonic growth phenotype [14]. Careful studies have revealed effects on mammalian behaviour for several genes [6,7,15-19] which suggests that the role of genomic imprinting may be more complex or that some genes are imprinted by virtue of their proximity to imprinting centres (ICs).
###end p 10
###begin p 11
###xml 293 295 293 295 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 296 298 296 298 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 405 407 405 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
###xml 263 267 <span type="species:ncbi:10090">mice</span>
###xml 306 310 <span type="species:ncbi:10090">mice</span>
While studies on loss of function are important for our understanding of gene function by itself, over expression studies may provide more unequivocal information on the significance of imprinting of a particular gene. Biallelic gene expression can be studied in mice with uniparental disomy [20-22] or in mice where a targeted deletion of an imprinting centre (IC) has released genes from imprinting [23-25]. These studies generally involve multiple genes and, in regions where there are both paternally and maternally expressed genes, can also involve loss of expression. The primary advantage of using large genomic clones to analyse imprinted genes is that the exact nature and number of genes is defined by the transgenic sequence, there is no loss of expression and the genes are expressed from their endogenous promoters at the appropriate level and time, predominantly without being affected by the site of integration [26].
###end p 11
###begin p 12
###xml 0 6 0 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 22 25 22 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">p57</italic>
###xml 25 29 25 29 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Kip2</italic>
###xml 25 29 25 29 <sup xmlns:xlink="http://www.w3.org/1999/xlink"><italic>Kip2</italic></sup>
###xml 105 107 105 107 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 108 110 108 110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B30">30</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 226 233 226 233 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 332 334 332 334 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 335 337 335 337 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN1C </italic>
###xml 429 431 429 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 432 434 432 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 497 499 497 499 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B27">27</xref>
###xml 500 502 500 502 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B28">28</xref>
###xml 526 533 526 533 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 589 591 589 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B38">38</xref>
###xml 597 604 597 604 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 623 629 623 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nurr1 </italic>
###xml 696 698 696 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B39">39</xref>
###xml 364 370 <span type="species:ncbi:9606">humans</span>
Cdkn1c, also known as p57Kip2, encodes a maternally expressed, cyclin-dependant kinase inhibitor (CDKi) [27-30]. Expression is tissue-specific and at high levels in cells entering mitotic arrest [27,28]. Loss of expression of Cdkn1c through maternal inheritance of a targeted deletion results in severe developmental abnormalities [31,32], similar to that seen in humans with loss of CDKN1C in Beckwith-Wiedemann syndrome (BWS) [33-37]. As with all CDKis, excess Cdkn1c induces cell cycle arrest [27,28]. Forced expression of Cdkn1c in retinal cultures leads to premature cell cycle exit [38] and Cdkn1c co-expression with Nurr1 promotes maturation of a midbrain dopaminergic neuronal cell line [39] demonstrating a role for Cdkn1c in both cell cycle regulation and cellular differentiation.
###end p 12
###begin p 13
###xml 4 11 4 11 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 99 101 99 101 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B29">29</xref>
###xml 220 222 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 316 318 316 318 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 319 321 319 321 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B40">40</xref>
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B41">41</xref>
###xml 341 348 341 348 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 387 394 387 394 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 395 397 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 457 464 457 464 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Nap1l4 </italic>
###xml 624 627 624 627 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Th </italic>
###xml 657 659 657 659 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 926 930 926 930 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 995 1002 995 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 72 77 <span type="species:ncbi:10090">mouse</span>
###xml 403 407 <span type="species:ncbi:10090">mice</span>
###xml 877 881 <span type="species:ncbi:10090">mice</span>
The Cdkn1c gene is located within a large cluster of imprinted genes on mouse distal chromosome 7 [29]. Maternal disomy of this region results in embryonic and extra embryonic growth retardation and embryonic lethality [22]. There are two ICs within this domain controlling two mechanistically distinct sub domains [25,40,41]. Imprinting of Cdkn1c is achieved through IC2, also known as KvDMR1 [25] and mice paternally inheriting a targeted deletion of the KvDMR1 locus show growth retardation. Growth retardation is also associated with maternal transmission of an 800 kb YAC transgene spanning eleven genes from Nap1l4 to Th but excluding the IC1 domain [42]. All these studies involve multiple imprinted genes and dissecting which gene is responsible for a particular phenotype is not straightforward. Nonetheless, the proportionality of the growth retardation in all these mice suggests a systemic effect on growth. Since Igf2, which encodes a potent embryonic mitogen, is unaffected by the KvDMR1 deletion, one or more of the other deregulated genes may play a novel role in regulating whole organism growth.
###end p 13
###begin p 14
###xml 144 150 144 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 356 362 356 362 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 405 412 405 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 444 451 444 451 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 49 53 <span type="species:ncbi:10090">mice</span>
###xml 533 538 <span type="species:ncbi:10090">mouse</span>
In this study, we characterised the phenotype of mice carrying different copy number integrations of a bacterial artificial chromosome spanning Cdkn1c. We show copy-number dependent embryonic growth retardation that is most severe on the 129/Sv genetic background. By using a modified BAC transgene spanning the same genomic region but with an inactivated Cdkn1c, we can assign the embryonic phenotype to Cdkn1c alone. These data indicate that Cdkn1c encodes the most important regulator of embryonic growth within the IC2 domain on mouse distal chromosome 7.
###end p 14
###begin title 15
Results
###end title 15
###begin title 16
###xml 7 14 7 14 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
Excess Cdkn1c causes embryonic lethality
###end title 16
###begin p 17
###xml 79 86 79 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 87 89 87 89 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B43">43</xref>
###xml 90 92 90 92 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 147 162 147 162 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c in vivo </italic>
###xml 276 283 276 283 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 290 292 290 292 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 302 304 302 304 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 468 469 468 469 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 535 536 535 536 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T1">1</xref>
###xml 697 698 697 698 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 915 916 915 916 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 191 206 <span type="species:ncbi:10090">transgenic mice</span>
Following on from our previous work on studying the mechanism of imprinting of Cdkn1c [43,44], we investigated the consequences of over expressing Cdkn1c in vivo on development. We generated transgenic mice carrying an 85 kb bacterial artificial chromosome (BAC) spanning the Cdkn1c locus [44] (Figure 1A). When ES cell lines with low copy number insertions of this transgene (1-4) were aggregated with MF1 morulae, there was a high incidence of perinatal loss (Table 1). No live born chimeras were obtained for high copy lines (Table 1). When surviving chimeras from four independent lines were crossed to out bred MF1 females, transgenic offspring were detected at the expected frequency (Table 2). When these same chimeras were crossed with 129/Sv females, transgenics were recovered at low frequency in a single copy line (1/33) and not at all in three other lines containing 2-4 copies of the transgene (Table 2). We examined litters at earlier time points and dying transgenic embryos were observed at varying stages, some as early as E10.5 (Line 5B6, four copies).
###end p 17
###begin p 18
###xml 0 179 0 179 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Physical map of the telomeric end of the imprinted domain in mouse distal chromosome 7 in relation to the position of the BAC transgene and expression analysis of transgenic lines</bold>
###xml 286 293 286 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 503 510 503 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 601 607 601 607 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phlda2</italic>
###xml 609 618 609 618 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc22a18 </italic>
###xml 622 628 622 628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 667 674 667 674 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Napl14 </italic>
###xml 762 785 759 782 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase-neomycin </italic>
###xml 791 794 785 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">geo</italic>
###xml 822 829 816 823 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 996 1002 990 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1432 1439 1426 1433 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1529 1543 1523 1534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 1555 1562 1546 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1616 1621 1607 1612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh</italic>
###xml 1623 1629 1614 1620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Actin </italic>
###xml 1633 1637 1624 1628 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S </italic>
###xml 1642 1649 1633 1640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1754 1761 1745 1752 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1826 1840 1817 1828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 1875 1882 1863 1870 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 2159 2166 2147 2154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 241 246 <span type="species:ncbi:10090">mouse</span>
Physical map of the telomeric end of the imprinted domain in mouse distal chromosome 7 in relation to the position of the BAC transgene and expression analysis of transgenic lines. A) Top line shows a genomic map of the IC2 region on distal mouse chromosome 7. Hatched region marks the KvDMR1 region that is methylated only on the maternal allele. The black arrowhead marks the position of the IC2 control region for the domain. Arrows indicate direction of transcription. Below is the map of the 85 kb Cdkn1c transgene (BAC144D14). Filled boxes show the positions of the intact genes. In addition to Phlda2, Slc22a18 and Cdkn1c, the transgene includes the 3' UTR of Napl14 (white box) but not the 5' UTR. The modified BAC used to generate line 10-15 has a beta-galactosidase-neomycin (beta-geo) fusion gene inserted into Cdkn1c indicated by the white arrowhead and black filled box. B) Localisation of the Cdkn1c protein expressed from the BAC transgene. Sagittal section of E12.5 wild type and Cdkn1c-null/BAC transgene (KO/Tg) embryos stained with a Cdkn1c-specific antibody. Endogenous Cdkn1c is most strongly expressed in skeletal and cardiac muscle, cartilage and the developing pituitary with lower expression in neuronal tissues. The transgenic expression is predominantly only neural, indicated by the black arrows, and in a subset of cells in the pituitary, kidney, lung and adrenal gland. C) Quantitative RT-PCR data for Cdkn1c at E13.5 for 5D3 (single copy line) and 5A4 (two copy line) transgenic embryos and 10-15 (Cdkn1c-betageo) at E12.5. Cdkn1c levels were normalised against three reference genes: Gapdh, Actin and 18S RNA. Cdkn1c was at 1.36-fold wild type levels in the single copy line and 1.75-fold endogenous in the two copy line. Cdkn1c levels were not significantly raised in the control line, 10-15 (Cdkn1c-betageo). D) Quantitative RT-PCR data for Cdkn1c at E12.5 for 5D3 (single copy line) showing the difference in expression between head, where the transgene is predominantly expressed, and the body, where the transgene is only expressed in a small subset of tissues. This is consistent with copy number dependent expression of Cdkn1c from the transgene in a subset of tissues.
###end p 18
###begin p 19
Contribution of transgenic ES cells to coat colour and germ line transmission in chimeras.
###end p 19
###begin p 20
129/Sv ES were aggregated with MF1 morula to generate chimaeric animals containing both ES cells (agouti) and the host MF1 cells (albino). The contribution of ES to the adult chimera was estimated by the percentage of agouti in the coat colour and found to decrease with increasing copy number. Additionally, 50% (21/40) of the pups with dark eyes (d.e.), indicating a strong contribution of ES cells, were born dead or die shortly after birth.
###end p 20
###begin p 21
n.t. = not tested.
###end p 21
###begin p 22
Embryonic lethality in transgenic animals on pure a 129/Sv background.
###end p 22
###begin p 23
###xml 81 83 81 83 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 586 588 586 588 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 725 727 725 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The transgene was present at the expected frequency (50% of the adult offspring, P = 0.5) when chimeras were mated with MF1 females but there was a significant reduction in survival of transgenics for single copy line 5D3 (number of transgenic animals/total number genotyped = 1/35, *P = 0.0001) and no survivors for the other lines when chimaeras were crossed with inbred 129/Sv females. F1 males from line 5D3 (50%:50%; MF1 x 129/Sv) were backcrossed onto 129/Sv for three generations (G3). At which point significant lethality was again noted (1/33 transgenics from eight litters, **P = 0.06). The modified transgene (10-15) bred six generations into the 129/Sv background showed no significant difference in survival (***P = 0.20).
###end p 23
###begin p 24
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 136 144 136 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 159 161 159 161 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 325 327 325 327 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 367 374 367 374 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 590 592 590 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 782 784 782 784 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1D</xref>
###xml 941 948 941 948 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1011 1018 1011 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1048 1056 1048 1056 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in situ </italic>
###xml 1109 1111 1109 1111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1118 1125 1118 1125 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1214 1221 1214 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1313 1320 1313 1320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1563 1569 1563 1569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1638 1645 1638 1645 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
We have previously shown that the transgenic Cdkn1c transcript is expressed only in a subset of tissues from this 85 kb BAC at E13.5 by in situ hybridisation [44]. Immunohistochemistry with a Cdkn1c-specific antibody showed a similarly restricted distribution of the Cdkn1c protein at E12.5, mainly to neural tissues (Figure 1B). Real Time RT-PCR measurements of the Cdkn1c transcript revealed an increase in the overall expression of 1.36-fold in whole embryos carrying a single copy of the BAC transgene (line 5D3) and 1.75-fold in embryos carrying two copies (line 5A4) at E13.5 (Figure 1C). This reflects the restricted expression from the BAC which we confirmed in E12.5 embryos by comparing the levels of expression in the head versus the body in the single copy line (Figure 1D). This is consistent with expression from the single-copy transgene at levels similar to the endogenous gene in neural tissues where we know the transgenic Cdkn1c to be expressed. We were not able to detect over expression of Cdkn1c in the body. We know from our in situ data, immunohistochemistry and a reporter transgene [44] that Cdkn1c is expression from the BAC in only a subset of the non-neuronal tissues where endogenous Cdkn1c is expressed such as the lung endothelium and the developing kidney tubules. The endogenous Cdkn1c is expressed most strongly in skeletal muscle and cartilage, where we do not see expression from our transgene. This very strong expression maybe masking the more subtle changes in tissues where there is a relatively lower level expression of Cdkn1c. These data are consistent with copy-number dependent expression of Cdkn1c from the BAC in a subset of tissues.
###end p 24
###begin title 25
###xml 49 55 49 55 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
Growth is exquisitely sensitive to the dosage of Cdkn1c
###end title 25
###begin p 26
###xml 269 271 269 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
The transgenic offspring from the cross between the chimeric males and the MF1 females were noticeably smaller than their wild type littermates. The degree of growth retardation increased with increasing copy number of the transgene and persisted after weaning (Figure 2A). Persistent growth retardation was also observed when the single copy transgene was bred onto the C57/BL6 background for three generation (Fig 2B).
###end p 26
###begin p 27
###xml 46 53 46 53 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 0 62 0 62 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Postnatal growth retardation in mice carrying <italic>Cdkn1c </italic>transgene</bold>
###xml 359 360 359 360 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 366 368 366 368 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1144 1145 1144 1145 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
###xml 1152 1154 1152 1154 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1374 1376 1374 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 1453 1460 1453 1460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1540 1546 1540 1546 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1721 1728 1721 1728 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1797 1804 1797 1804 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 32 36 <span type="species:ncbi:10090">mice</span>
###xml 250 254 <span type="species:ncbi:10090">Mice</span>
###xml 426 430 <span type="species:ncbi:10090">mice</span>
###xml 769 773 <span type="species:ncbi:10090">mice</span>
Postnatal growth retardation in mice carrying Cdkn1c transgene. A) Post natal growth curves of males from one to eight weeks for lines 5D3 (one copy, n = 2), 5A4 (two copy, n = 3) and 5B6 (four copies, n = 2) and their wild type littermates (n = 9). Mice carrying the transgene are significantly smaller in all lines (Statistical significance using Student's t-test P < 0.017 for all lines). All weights were obtained from F1 mice born from a cross between a chimaeric male founder (129/Sv) and a MF1 female. B) Post natal weight data from one to ten weeks of males for the single copy line, 5D3, bred onto the C57/BL6 background for three generation showing persistence of growth retardation after weaning (one copy, Tg n = 9, WT n = 8). C) Weights at 3 weeks of male mice from line 5D3 (one copy, Tg n = 4, WT n = 9) on a 50%:50%; 129/Sv x MF1 background labelled as 5D3/MF1) compared with a 75%:25% background labelled as 5D3/129 (Tg n = 6, WT n = 8). Interaction with a genetic factor within the 129/Sv background results in a more severe growth retardation, increasing from 11.3% to 28.8% (Statistically significant change using Student's t-test. P = 0.014). On a C57BL/6 background, the growth retardation is intermediate at 20.5% (Tg n = 9, WT n = 8). No significant growth retardation is observed in transgenic line 10-15 on a 129/Sv background (Tg n = 8, WT n = 4, P = 0.24). This line carries three copies of the modified BAC where transgenic Cdkn1c is not functional demonstrating that growth retardation is likely due to excess Cdkn1c. C) Comparison of organ weights in wild type and 5D3 transgenic adult males at 8-10 weeks. Growth retardation is not restricted to organs in which there was excess embryonic Cdkn1c WT n = 9 and Tg n = 6). *denotes tissues that were exposed to excess Cdkn1c during embryogenesis.
###end p 27
###begin p 28
###xml 349 351 349 351 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 378 380 378 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 503 505 503 505 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
###xml 507 509 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The degree of growth retardation also varied with strain background. Transgenic F1 males (50%:50%; 129/Sv:MF1) from a single copy line, 5D3, were 11.3% smaller at three weeks but when these males were crossed with 129/Sv females, the transgenic F2 male offspring (75%:25%; 129/Sv:MF1) were 29% smaller than their non-transgenic litter mates (Figure 2C, two tail student t-Test: P = 0.017). Generation 3 C57B/L6 males showed an intermediate phenotype of 20% growth retardation at this time point (Figure 2C, P = 0.02). In contrast the lethality associated with an increasing contribution of the 129/Sv genetic background, no evidence of lethality was associated with the presence of a single copy of the transgene on the C57BL/6 background (data not shown).
###end p 28
###begin p 29
###xml 250 251 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 475 476 475 476 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T3">3</xref>
###xml 650 657 650 657 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 658 660 658 660 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 667 673 667 673 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 837 844 837 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 155 159 <span type="species:ncbi:10090">mice</span>
###xml 684 688 <span type="species:ncbi:10090">mice</span>
We examined the age at which males acquired sexual maturity as judged by the timing of their first mating. Despite their small size, transgenic male adult mice reached sexual maturity at the same time as wild type littermates and were fertile (Table 3). The majority of females also reached sexual maturity at a similar age to their wild type littermates but there was one female that had a litter late and two that did not have litters during the time of observation (Table 3). Those that had litters were able to nest and feed their offspring. It should be noted that there is variable fertility in the rare surviving females that are deficient in Cdkn1c [45]. The Cdkn1c-deficient mice also show a severe postnatal growth defect. This is consistent with a defect in pituitary development. It is possible that, given the expression of Cdkn1c from our transgene in the pituitary, further studies on transgenics animals with a higher 129/Sv genetic contribution might reveal an endocrine defect in adults and this is under investigation.
###end p 29
###begin p 30
Excess Cdkn1c does not affect sexual maturity.
###end p 30
###begin p 31
###xml 111 113 111 113 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 255 257 255 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
There was no significance difference in time to first plug between transgenic males and wild type littermates (P = 0.33). Transgenic females had their litters slightly later than wild type females. Although this difference did not show up as significant (P = 0.22), there was a large variation in timing within the transgenic females from 56 to 69 days. Furthermore, two females in this study never became pregnant.
###end p 31
###begin p 32
###xml 145 152 145 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 257 264 257 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 349 356 349 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2D</xref>
###xml 655 662 655 662 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
Cdkn1c is a cell cycle inhibitor that acts intrinsically to limit cell proliferation. We would expect that the tissues in which there was excess Cdkn1c would be disproportionately smaller than those without. We examined the weights of organs with no excess Cdkn1c (heart, spleen, testes and liver) and those in which there had been excess embryonic Cdkn1c (kidney and brain, Figure 2D) in eight-week old males. There were no significant difference in comparison to body weight (P = 0.12-0.87) between wild type and transgenic males. Growth retardation induced by the presence of a single copy BAC was not restricted to the tissues in which the transgenic Cdkn1c was expressed.
###end p 32
###begin p 33
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A</xref>
###xml 241 243 241 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3B</xref>
###xml 245 247 245 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 257 259 257 259 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
###xml 316 323 316 323 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 407 409 407 409 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 410 412 410 412 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 445 452 445 452 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 504 506 504 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D</xref>
###xml 508 510 508 510 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
The transgenic embryos were small but similar in appearance to wild type embryos (Figure 3A) in all four lines. At E13.5, transgenic embryos from line 5D3 (single copy) on a mixed MF1:129/Sv background are 14% smaller than wild type (Figure 3B; P = 7.2 x 10-7). This phenotype is comparable to that reported for the KvDMR1 deletion and the 800 kb YAC where several additional genes are also over expressed [25,42]. In contrast, embryos null for Cdkn1c were 11% heavier wild type embryos at E13.5 (Figure 3D, P = 0.008).
###end p 33
###begin p 34
###xml 45 52 45 52 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 0 58 0 58 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Embryonic growth is exquisitely sensitive to <italic>Cdkn1c </italic>levels</bold>
###xml 530 532 530 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 542 544 542 544 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-7</sup>
###xml 677 684 677 684 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 704 710 704 710 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 872 874 872 874 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 977 984 977 984 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1012 1018 1012 1018 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1165 1167 1165 1167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
Embryonic growth is exquisitely sensitive to Cdkn1c levels. A) Image of a wild type and a transgenic embryo from line 5A4 (two copies) at E16.5 shows demonstrable growth retardation. The embryos appear normally proportioned. B) A comparison of wild type and transgenic embryo weights at E13.5 for line 5D3 (single copy unmodified BAC, Tg n = 22, WT n = 21). These embryos are from 129/Sv females mated with transgenic males maintained on an MF1 background. Transgenic embryos weigh significantly less than wild type embryos (86%, P = 7.2 x 10-7). C) A comparison of wild type and transgenic weight at E13.5 of embryos for line 10-15 (three copy BAC with an inactive transgenic Cdkn1c locus and no excess Cdkn1c, Tg n = 30, WT n = 22). The line was maintained on a 129/Sv background. Transgenic embryos are not significantly different in weight to wild type embryos (104%, P = 0.24). D) A comparison of wild type and transgenic weights at E13.5 of embryos inheriting a targeted Cdkn1c allele maternally (null for Cdkn1c, Tg n = 19, WT n = 16). The line was maintained on a 129/Sv background. Transgenic embryos weigh significantly more than wild type embryos (111%, P = 0.008).
###end p 34
###begin title 35
###xml 27 33 27 33 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
Phenotype is due to excess Cdkn1c
###end title 35
###begin p 36
###xml 37 44 37 44 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phlda2 </italic>
###xml 59 63 59 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ipl </italic>
###xml 66 71 66 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tssc3</italic>
###xml 74 76 74 76 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B46">46</xref>
###xml 82 91 82 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc22a18 </italic>
###xml 106 112 106 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Impt1 </italic>
###xml 115 120 115 120 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Tssc5</italic>
###xml 123 125 123 125 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 310 324 310 321 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 383 390 380 387 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 471 473 468 470 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 476 478 473 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 496 503 493 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 547 549 544 546 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 552 559 549 556 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phlda2 </italic>
###xml 563 571 560 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc22a18</italic>
###xml 635 637 632 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B45">45</xref>
###xml 638 640 635 637 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B47">47</xref>
###xml 686 688 683 685 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 490 494 <span type="species:ncbi:10090">mice</span>
The transgene spans two other genes, Phlda2 (also known as Ipl or Tssc3) [46] and Slc22a18 (also known as Impt1 or Tssc5) [47]. The growth retardation and embryonic lethality could be a consequence of over expression of any one of these genes. To test this possibility, we examined the transgenic line, 10-15 (Cdkn1c-betageo). This line contains three copies of the same BAC but the Cdkn1c gene on the BAC has been inactivated by the insertion of a reporter gene (Figure 1A) [44]. In these mice, Cdkn1c is not over expressed in the embryo (Figure 1C). Phlda2 and Slc22a18, which are predominantly expressed in extra embryonic tissues [45,47], are highly over expressed in the placenta [48] but not detectable in the embryo at E13.5 (data not shown).
###end p 36
###begin p 37
###xml 156 157 156 157 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="table" rid="T2">2</xref>
###xml 443 457 443 454 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 508 510 505 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 512 514 509 511 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 551 565 548 559 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 633 635 627 629 <italic xmlns:xlink="http://www.w3.org/1999/xlink">P </italic>
###xml 660 662 654 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 97 101 <span type="species:ncbi:10090">mice</span>
No embryonic lethality was observed when we first generated this line or when we backcrossed the mice for six generations onto the 129/Sv background (Table 2). This contrasts with almost complete loss of transgenic animals (1/34 transgenic/wild type) after crossing 5D3 F1 males (50:50; 129/Sv x MF1) onto the 129/Sv background for three generations (>93% 129/Sv). There was no significant difference in weights between males from line 10-15 (Cdkn1c-betageo) and wild type littermates at three weeks (Figure 2B, P = 0.24) and embryos from line 10-15 (Cdkn1c-betageo) are not significantly different to their wild type counter parts (P = 0.24) at E13.5 (Figure 3C). This line was generated by pronuclear injection and it was possible that we selected against any transgenic lines showing an adverse phenotype. Therefore, we also examined embryos at E13.5 after a second round of pronuclear injection. Seven embryos representing independent integration events were identified. No significant difference in embryonic size was noted (data not shown).
###end p 37
###begin p 38
###xml 117 122 117 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 133 135 133 135 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 230 237 230 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phlda2 </italic>
###xml 244 253 244 253 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc22a18 </italic>
###xml 255 257 255 257 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 323 330 323 330 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 345 359 345 356 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 446 448 443 445 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B48">48</xref>
###xml 476 482 473 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 578 592 575 586 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 640 642 634 636 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3C</xref>
###xml 713 720 707 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 898 900 892 894 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B49">49</xref>
###xml 970 972 964 966 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 71 75 <span type="species:ncbi:10090">mice</span>
###xml 861 865 <span type="species:ncbi:10090">mice</span>
###xml 907 911 <span type="species:ncbi:10090">mice</span>
Placental insufficiency can also cause embryonic growth retardation in mice as illustrated by the placental specific Igf2 knock out [49]. Both the unmodified and modified BAC transgenic lines have a placental defect due to excess Phlda2 and/or Slc22a18 ([48] and our unpublished data). In the absence of over expression of Cdkn1c in line 10-15 (Cdkn1c-betageo), this placental defect leads to a slow down in embryonic growth detectable at E16.5 [48]. In the lines with excess Cdkn1c, we observe embryonic growth retardation three days earlier, at E13.5. Our control line 10-15 (Cdkn1c-betageo) embryos are of normal weight at E13.5 (Figure 3C). Therefore, this earlier defect in embryonic growth is due to excess Cdkn1c and not due to the placental insufficiency shared by both lines. Furthermore, a key characteristic of IUGR due to placental insufficiency in mice is postnatal "catch up" growth [49]. Our mice do not recover their growth potential after birth (Figure 2A). Even at one year, they are noticeably smaller than their wild type siblings (data not shown).
###end p 38
###begin p 39
###xml 28 35 28 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
We can conclude that excess Cdkn1c in the embryo causes sustained growth retardation and, on the 129/Sv genetic background, also causes embryonic lethality.
###end p 39
###begin title 40
###xml 0 5 0 5 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 57 64 57 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
Igf1 expression is reduced as a consequence of increased Cdkn1c levels
###end title 40
###begin p 41
###xml 559 564 559 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 618 623 618 623 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 752 754 752 754 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4A</xref>
###xml 757 762 757 762 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 868 870 868 870 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4B</xref>
Cdkn1c acts intrinsically to regulate cell proliferation and, in some tissues, also directs differentiation. However, growth retardation was not limited to the tissues in which there was an embryonic excess Cdkn1c. One possible explanation was that excess Cdkn1c altered the expression level of one of the key embryonic growth regulatory genes which would then have an extrinsic effect on growth. We used quantitative Real Time RT-PCR to measure the transcript levels of several genes known to regulate embryonic growth. At E11.5 we identified a reduction in Igf1 in our two-copy line but not in our single-copy line. Igf1 was reduced in both the single-copy and the two-copy transgenic lines at E13.5 when there was obvious growth retardation (Figure 4A). Igf2 levels were slightly raised at E11.5 in both lines and reduced at E13.5 only in the two-copy line (Figure 4B).
###end p 41
###begin p 42
###xml 89 95 89 95 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 0 95 0 95 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Quantitative analysis of growth factor expression levels in response to excess embryonic <italic>Cdkn1c</italic></bold>
###xml 129 134 129 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 216 221 216 221 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 277 282 277 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 336 341 336 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 422 427 422 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 492 497 492 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 550 555 550 555 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 628 635 628 635 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 662 667 662 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 738 745 738 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 828 833 828 833 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 909 914 909 914 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 937 942 937 942 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 1039 1044 1039 1044 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
Quantitative analysis of growth factor expression levels in response to excess embryonic Cdkn1c. A) Quantitative RT-PCR data for Igf1 on whole embryos from lines 5D3 and 5A4. At E11.5, there is a slight reduction in Igf1 in the two-copy line. At E13.5, there is a reduction in Igf1 levels in both lines. B) Quantitative RT-PCR data for Igf2 on whole embryos from lines 5D3 and 5A4. At E11.5, there is a slight increase in Igf2 in both lines while at E13.5, there is a significant decrease in Igf2 in the two-copy line. C) Comparison of expression of Igf1 at E12.5 in the single copy line, 5D3, head compared with body and whole Cdkn1c null embryos. In line 5D3, Igf1 levels are 60% less than wild type levels in the head where transgenic Cdkn1c is predominantly expressed but relatively unaffected in the body. In null embryos, Igf1 levels are raised by three-fold in the head. D) Comparison of expression of Igf2 at E12.5. In line 5D3, Igf2 levels are raised by two-fold in the head but 50% wild type levels in the body. In null embryos, Igf2 levels are similar to wild type.
###end p 42
###begin p 43
###xml 53 58 53 58 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 237 242 237 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 246 251 246 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 333 340 333 340 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 596 601 596 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 676 678 676 678 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 743 748 743 748 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 860 865 860 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 866 868 866 868 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B50">50</xref>
###xml 869 871 869 871 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B51">51</xref>
###xml 969 974 969 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 1034 1039 1034 1039 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 1175 1180 1175 1180 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 1181 1182 1181 1182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
In the single copy line, we only detected changes in Igf1 at E13.5, when the growth retardation phenotype was well established. In order to detect more subtle changes in gene expression at an earlier time point in this line, we examined Igf1 and Igf2 levels in RNA prepared separately from the head and in the body of E12.5 embryos. Cdkn1c expression from our transgene was predominantly in neural tissues and we reasoned that we would be more likely to detect a change in expression in material where this tissue predominates. When we examined the transgenic embryos, we found that the level of Igf1 in the head was dramatically reduced to 40% of the wild type level (Figure 4C). In the body, where we have minimal over expression of Cdkn1c, Igf1 levels were not significantly changed from normal. The central nervous system is a major site for expression of Igf1 [50,51]. Consistent with this observation, we found that, in wild type embryos, there was 9.5-fold more Igf1 RNA in the head than in the body at E12.5 (data not shown). Igf2 levels were raised in the head by two-fold and reduced in the body by 50%. Since the body (mesodermal tissues) is the primary source of Igf2 [2], the overall change in expression in the transgenic embryos was not significant.
###end p 43
###begin p 44
###xml 88 93 88 93 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 97 102 97 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 171 178 171 178 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 241 246 241 246 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 276 281 276 281 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 360 362 360 362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4C</xref>
###xml 365 370 365 370 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 427 429 427 429 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4D</xref>
To provide further data to support a role for Igf1 in the growth phenotype, we examined Igf1 and Igf2 levels in RNA prepared from the heads and bodies of embryos null for Cdkn1c at E12.5. We again found changes in the level of expression of Igf1 with a three-fold increase in Igf1 expression levels in the head and difference in expression in the body (Figure 4C). Igf2 levels were relatively unchanged in both samples (Figure 4D).
###end p 44
###begin p 45
###xml 72 79 72 79 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 135 139 135 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1</italic>
###xml 227 232 227 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 308 315 308 315 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
We have found an inverse correlation between the level of expression of Cdkn1c and the level of expression of the potent growth factor Igf1. These data are consistent with a role for this growth factor in our growth phenotype. Igf1 levels are linked, either directly or indirectly, to level of expression of Cdkn1c and growth is either retarded or enhanced as a consequence.
###end p 45
###begin p 46
We have shown that Cdkn1c acts as a true rheostat for embryonic growth, with loss of expression after gene deletion leading to overgrowth and over expression of Cdkn1c causing growth retardation.
###end p 46
###begin title 47
Discussion
###end title 47
###begin title 48
###xml 59 65 59 65 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
Embryonic growth is exquisitely sensitive to the dosage of Cdkn1c
###end title 48
###begin p 49
###xml 21 28 21 28 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 194 201 194 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 284 291 284 291 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B32">32</xref>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 483 490 483 490 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 296 300 <span type="species:ncbi:10090">mice</span>
Excess expression of Cdkn1c from a single copy BAC transgene resulted in decreased growth of embryos from at least E13.5 with no catch-up growth after birth. Furthermore, as the level of excess Cdkn1c increased, the size of the animals decreased. Initial reports for the phenotype of Cdkn1c null mice did not reveal a clear affect on growth at birth [31,32]. However, we found that loss of Cdkn1c was associated with embryonic overgrowth earlier in development, at E13.5. Therefore, Cdkn1c acts as a true rheostat for embryonic growth.
###end p 49
###begin title 50
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
Cdkn1c is the most important regulator of embryonic growth within the IC2 domain
###end title 50
###begin p 51
###xml 498 500 498 500 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 529 534 529 534 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 538 543 538 543 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins2 </italic>
###xml 606 612 606 612 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 614 620 614 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ascl2 </italic>
###xml 624 631 624 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phlda2 </italic>
###xml 653 654 653 654 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5</xref>
###xml 708 714 708 714 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1</italic>
###xml 832 834 832 834 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 929 931 929 931 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B42">42</xref>
###xml 1073 1080 1073 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Phlda2 </italic>
###xml 1084 1093 1084 1093 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Slc22a18 </italic>
###xml 1108 1114 1108 1114 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1136 1143 1136 1143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 391 396 <span type="species:ncbi:10090">mouse</span>
Studies on mono-parental embryos and embryos with paternal or maternal disomy of specific chromosomal regions revealed a key role for imprinted genes in regulating embryonic growth. These studies invariably involved both loss of expression and excess expression of multiple genes and the identification of the target for imprinting of the locus is difficult. Embryos with maternal disomy of mouse distal chromosome 7 showed embryonic and extra embryonic growth retardation and embryonic lethality [22] with loss of expression of Igf2 and Ins2 and excess expression of a number of genes presumed to include Cdkn1c, Ascl2 and Phlda2 (summarised in Figure 5). Paternal inheritance of a targeted deletion of the KvDMR1, which resulted in loss of imprinting of only the IC2 domain, resulted in a slightly less severe growth retardation [25] similar to maternal inheritance of the 800 kb YAC spanning all the genes within this domain [42]. Our unmodified BAC, which spans only three of these genes, also caused embryonic growth retardation. The modified BAC, which drives excess Phlda2 and Slc22a18 but not excess Cdkn1c, did not. Therefore, Cdkn1c is the only gene in this region that has been shown to have a major role in regulating embryonic growth.
###end p 51
###begin p 52
###xml 0 108 0 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c is the key regulator of embryonic growth within the IC2 imprinted domain on mouse distal chromosome 7</bold>
###xml 533 540 533 540 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 83 88 <span type="species:ncbi:10090">mouse</span>
###xml 198 203 <span type="species:ncbi:10090">mouse</span>
Cdkn1c is the key regulator of embryonic growth within the IC2 imprinted domain on mouse distal chromosome 7. Summary of the reported genotypes and phenotypes associated with the imprinted genes on mouse distal chromosome 7. Black arrowheads indicate the positions of the known IC for the two domains. The number of expressed gene copies present in each genotype is shown with the top row being the normal, wild type state. The reported weight phenotypes are for maternal disomy distal chromosome 7 [22], paternal inheritance of the KvDMR1 deletion [25], maternal inheritance of an 800 kb YAC [42] and data from this paper. The strain backgrounds are C57BL/6 where indicated.
###end p 52
###begin title 53
###xml 96 102 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
Embryonic lethality in embryos with maternal disomy of the distal 7 domain may be due to excess Cdkn1c
###end title 53
###begin p 54
###xml 137 144 137 144 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KvDMR1 </italic>
###xml 285 290 285 290 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 297 301 297 301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins2</italic>
###xml 366 371 366 371 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 372 373 372 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 378 383 378 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Ins2 </italic>
###xml 384 386 384 386 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B52">52</xref>
###xml 455 460 455 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 472 478 472 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 540 547 540 547 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 558 563 558 563 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 228 232 <span type="species:ncbi:10090">mice</span>
There are differences in survival between embryos with maternal disomy of distal chromosome 7 and those with paternal inheritance of the KvDMR1 deletion. This could be interpreted to indicate that the embryonic lethality in the mice with maternal disomy of distal 7 was due to loss of Igf2 and/or Ins2. However, embryonic lethality was not been reported for loss of Igf2 [2] or Ins2 [52] alone. Although lethality could be due to a combination of loss of Igf2 with excess Cdkn1c, we have observed embryonic lethality associated with excess Cdkn1c and normal Igf2 levels on the 129/Sv genetic background.
###end p 54
###begin title 55
###xml 22 27 22 27 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 67 73 67 73 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
Altered expression of Igf1 in response to changes in the dosage of Cdkn1c
###end title 55
###begin p 56
###xml 53 60 53 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 160 167 160 167 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 272 276 272 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1</italic>
###xml 373 380 373 380 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 525 530 525 530 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 557 562 557 562 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 614 616 614 616 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B53">53</xref>
###xml 617 619 617 619 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 647 652 647 652 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 727 729 727 729 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B54">54</xref>
###xml 802 807 802 807 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 1000 1005 1000 1005 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
Our data showed that increasing expression levels of Cdkn1c were associated with a decrease in the size of the embryo, starting prior to E13.5. As the level of Cdkn1c increased, we found a consistent decrease in the transcript level of the potent embryonic growth factor, Igf1, which was detectable as early as E11.5 in our two-copy line. Conversely, loss of expression of Cdkn1c was associated with a reciprocal phenotype with the null embryos being 11% heavier than wild type embryos at E13.5 with a three-fold increase in Igf1 at E12.5. Complete loss of Igf1 results in embryonic growth retardation from E13.5 [53,54]. Similar to our 5D3 mice, Igf1 heterozygotes are 10-20% smaller at birth and remain this small as adults [54]. Although no significance size difference was reported at E13.5 in the Igf1 heterozygotes, genetic modifiers may provide an explanation for this discrepancy since our preliminary data suggest a weaker growth retardation phenotype in the C57BL/6 background on which the Igf1 studies have all been performed.
###end p 56
###begin p 57
###xml 99 103 99 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 135 142 135 142 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 177 184 177 184 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 280 282 280 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B55">55</xref>
###xml 410 415 410 415 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 480 486 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 614 621 614 621 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 749 754 749 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 157 161 <span type="species:ncbi:10090">mice</span>
###xml 189 193 <span type="species:ncbi:10090">mice</span>
###xml 253 257 <span type="species:ncbi:10090">mice</span>
###xml 728 732 <span type="species:ncbi:10090">mice</span>
We also observed disturbances in the level of expression of a second key growth factor transcript, Igf2. However, this was only in the Cdkn1c overexpressing mice and not in the Cdkn1c null mice. Also, we have some limited data from genetic crosses with mice over expressing Igf2 [55] that do not support a major role for this growth factor in our phenotype. It is therefore probable that reduced expression of Igf1 was responsible for growth retardation in the presence of excess Cdkn1c. This would also provide an explanation for why growth retardation was not restricted to the tissues in which there was excess Cdkn1c since Igf1 acts extrinsically to regulate growth. It will be possible to test this in genetic crosses when mice over expressing Igf1 from an endogenous promoter become available.
###end p 57
###begin p 58
###xml 62 68 62 68 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 83 87 83 87 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1</italic>
###xml 134 141 134 141 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 177 182 177 182 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
###xml 333 338 333 338 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1 </italic>
There are a number of ways in which the cell cycle inhibitor, Cdkn1c, could act on Igf1. Although we cannot exclude a direct role for Cdkn1c in regulating the expression of the Igf1 gene, it seems more plausible that the cell cycle inhibitor acts indirectly, for example by reducing the proliferative potential of the cells in which Igf1 is expressed or by altering the differentiation program of a particular cell type expressing the growth factor.
###end p 58
###begin p 59
While it has been known for some time that imprinting acts directly to regulate embryonic growth via the epigenetic modification of key genes, our data suggests that imprinting can also act indirectly to regulate the levels of non-imprinted embryonic growth factors. This further highlights the complexity and the importance of genomic imprinting in mammalian growth and development.
###end p 59
###begin title 60
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
Imprinting of Cdkn1c comes at a high cost
###end title 60
###begin p 61
###xml 89 91 89 91 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B33">33</xref>
###xml 92 94 92 94 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B37">37</xref>
###xml 123 130 123 130 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 227 229 227 229 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B56">56</xref>
###xml 371 373 371 373 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B57">57</xref>
###xml 374 376 374 376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B59">59</xref>
###xml 438 440 438 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B60">60</xref>
###xml 441 443 441 443 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B63">63</xref>
###xml 453 460 453 460 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CDKN1C </italic>
###xml 55 59 <span type="species:ncbi:10090">mice</span>
###xml 81 87 <span type="species:ncbi:9606">humans</span>
###xml 175 179 <span type="species:ncbi:10090">mice</span>
###xml 219 225 <span type="species:ncbi:9606">humans</span>
###xml 428 436 <span type="species:ncbi:9606">children</span>
###xml 498 504 <span type="species:ncbi:9606">humans</span>
Loss of expression of this gene is perinatal lethal in mice and linked to BWS in humans [33-37]. We have shown that excess Cdkn1c can be equally detrimental to development in mice and there is some evidence for this in humans [56]. Given the increased frequency of intrauterine growth retardation in babies conceived after assisted reproductive technologies conceptions [57-59] and a prevalence of imprinting mutations in these children [60-63], excess CDKN1C may be an important factor in IUGR in humans which should be explored further.
###end p 61
###begin title 62
###xml 14 21 14 21 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
Imprinting of Cdkn1c may have played a role in the transition towards increased maternal investment in embryonic growth in placental mammals
###end title 62
###begin p 63
###xml 215 222 215 222 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B64">64</xref>
###xml 550 552 550 552 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B66">66</xref>
###xml 571 584 571 584 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2, Cdkn1c </italic>
###xml 616 618 616 618 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B67">67</xref>
###xml 690 694 690 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2</italic>
###xml 800 806 800 806 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1041 1048 1041 1048 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
The parental conflict hypothesis predicts that over expression of a gene expressed only from the maternal genome should limit embryonic growth. We have presented the first compelling evidence that overexpression of Cdkn1c alone causes growth retardation and therefore the parental conflict hypothesis holds true for this gene. Our work may also provide further clues to the evolutionary consequence of imprinting this important gene. Imprinting has for some time been thought to have emerged prior to the divergence of marsupials from eutherians [64-66]. However, unlike Igf2, Cdkn1c is not imprinted in marsupials [67]. Therefore, the IC1 domain, containing the potent growth factor gene, Igf2, acquired an imprint prior to the divergence of marsupials and eutherians and the IC2 domain, containing Cdkn1c, became imprinted after this divergence. It may be significant that one key difference between marsupials and eutherians is the size and maturity of the offspring at birth and this correlates with the role that we have identified for Cdkn1c in regulating embryonic growth.
###end p 63
###begin title 64
Conclusion
###end title 64
###begin p 65
###xml 83 89 83 89 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 169 175 169 175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 183 190 183 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 287 294 287 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 371 378 371 378 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 603 610 603 610 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 748 755 748 755 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 46 50 <span type="species:ncbi:10090">mice</span>
By using different copy number transgenes and mice carrying a targeted deletion of Cdkn1c, we have shown that embryonic growth is exquisitely sensitive to the dosage of Cdkn1c. Since Cdkn1c encodes the major regulator of embryonic growth within the IC2 imprinted domain, we propose that Cdkn1c was the focal point of the selective pressure for imprinting of this domain. Cdkn1c is a maternally expressed gene and our findings support the prediction of the parental conflict hypothesis that that the paternal genome will silence genes that have an inhibitory role in embryonic growth. Furthermore, since Cdkn1c acquired its imprinted status after marsupials diverged from placental mammals, our data would support a role for the change in dosage of Cdkn1c gene in the relative increase size of the embryo in eutherians.
###end p 65
###begin title 66
Methods
###end title 66
###begin title 67
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice
###end title 67
###begin p 68
###xml 455 457 455 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 458 460 458 460 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B68">68</xref>
###xml 562 575 562 575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">pgk-neomycin </italic>
###xml 913 924 913 924 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Neuronatin </italic>
###xml 925 927 925 927 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B69">69</xref>
###xml 1662 1669 1662 1669 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1675 1689 1675 1686 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c-&#946;geo</italic>
###xml 1718 1720 1715 1717 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B44">44</xref>
###xml 1816 1823 1813 1820 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
###xml 1824 1826 1821 1823 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B31">31</xref>
###xml 1927 1929 1924 1926 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B70">70</xref>
###xml 207 211 <span type="species:ncbi:10090">mice</span>
###xml 320 324 <span type="species:ncbi:10090">mice</span>
###xml 857 862 <span type="species:ncbi:10090">mouse</span>
###xml 1729 1733 <span type="species:ncbi:10090">mice</span>
###xml 1781 1785 <span type="species:ncbi:10090">mice</span>
###xml 1833 1837 <span type="species:ncbi:10090">mice</span>
All animal studies and breeding was approved by the Universities of Cambridge and Cardiff ethical committees and performed under a UK Home Office project licenses. Inbred 129/Sv and C57BL/6 and out bred MF1 mice were maintained at the Gurdon Institute, Cambridge, UK and Cardiff School of Biosciences. Additional 129/Sv mice were purchased from B+K Universal. Transgenic lines carrying the 85 kb bacterial artificial chromosome were described previously [44,68]. Essentially, ES cell lines were made by co-electroporation of the linearised BAC with a linearised pgk-neomycin construct and selecting for neomycin positive colonies. Genomic DNA from these colonies was analysed by Southern blotting. Intactness and copy number of the BAC integrations was determined by probing the membrane first with the complete 85 kb BAC (after blocking repeats with total mouse genomic DNA) and then with a single copy probe to Neuronatin [69]. Lines carrying 1-8 copies of the BAC were co-cultured with MF1 morulae to generate chimaeric animals. The lines were maintained on a mixed 129/Sv x MF1 background. F1 5D3 (50%:50%; 129/Sv x MF1) denotes animals that have an equal contribution of MF1 and 129/Sv from a cross between a male chimera and a MF1 female, F2 5D3 (75%:25%; 129/Sv x MF1) denotes animals that have a greater contribution of 129/Sv obtained by crossing a F1 5D3 (50%:50%; 129/Sv x MF1) male with a 129/Sv female. Animals were genotyped by PCR using primers that identified the pBeloBAC vector sequence (R85: 5'-attctgcttacacacgatgc-3' and R86: 5'-ttccgcagaggtcaatcc-3'). Generation of line 10-15, which contains the modified BAC transgene with an inactivated Cdkn1c gene (Cdkn1c-betageo), was previously described [44]. These mice were maintained on a 129/Sv background as were mice carrying a targeted allele of Cdkn1c [31]. All mice were tailed between P7 and P14 and genomic DNA for genotyping was prepared as described [70].
###end p 68
###begin p 69
Sexual maturity was determined by daily checking for plugs and the appearance of a litter.
###end p 69
###begin title 70
Weighing studies
###end title 70
###begin p 71
Postnatal weights of males were taken at weekly intervals for one to eight weeks. At 8-10 weeks, males were killed by cervical dislocation. Organs were dissected and kept frozen on dry ice before weights were obtained. Embryonic weights were taken 11, 12 or 13 days after a discernable plug, at E11.5, 12.5 or 13.5. Embryos were stored in RNAlater (Sigma) while genotyping data was obtained from yolk sac DNA.
###end p 71
###begin title 72
Statistics
###end title 72
###begin p 73
###xml 81 82 81 82 <italic xmlns:xlink="http://www.w3.org/1999/xlink">t</italic>
Statistical significance (Probability values) was determined using the Student's t-Test (two tailed distribution and two sample unequal variance). The significance in the difference in observed over the expected appearance of a particular genotype was determined using the Chi-squared Test.
###end p 73
###begin title 74
Quantitative RNA analysis
###end title 74
###begin p 75
###xml 388 390 381 383 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B71">71</xref>
###xml 534 536 527 529 <sup xmlns:xlink="http://www.w3.org/1999/xlink">+ </sup>
###xml 542 544 535 537 <sup xmlns:xlink="http://www.w3.org/1999/xlink">- </sup>
###xml 1142 1148 1115 1121 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c</italic>
###xml 1212 1216 1185 1189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf1</italic>
###xml 1280 1285 1253 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Igf2 </italic>
###xml 1320 1323 1293 1296 <italic xmlns:xlink="http://www.w3.org/1999/xlink">18S</italic>
###xml 1325 1331 1298 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Gapdh </italic>
###xml 1335 1346 1308 1319 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Beta-actin </italic>
###xml 1384 1386 1357 1359 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B72">72</xref>
###xml 1387 1389 1360 1362 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B73">73</xref>
Total RNA was prepared from embryos using TRI Reagent (Sigma). cDNA was prepared using M-MuLV reverse transcriptase (Roche) with random hexamers under the manufacturers conditions. 20 mul cDNA was diluted five-fold in 10 mM Tris.HCl (pH 7.5) and stored at -20degreesC. For the quantitative PCR, primers were designed to amplify across introns for all the genes using the Primer3 program [71] unless otherwise stated. Quantitative RT-PCR was performed in duplicate on two independent samples and on two separate occasions on diluted RT+ and RT- material prepared for wild type and transgenic embryos using DyNAmo HS SYBR Green qPCR kit (Finnzymes), GRI 96 PCR detection plates and ABsolute QPCR seal (ABgene) and detected using the Chromo 4 Four-Color Real Time detector (MJ Research). Conditions for amplification: 15 minutes at 95degreesC (to release polymerase) followed by 40 cycles of 30 seconds at 95degreesC and 1 minute at 63degreesC (anneal and extension). 1 mul of diluted cDNA was amplified in a total sample volume of 25 mul with 25 pmoles of each primer. Primers were 5'-agagaactgcgcaggagaac-3' and 5'-tctggccgttagcctctaaa-3' for Cdkn1c, 5'-ggcattgtggatgagtgttg-3' and 5'-tctcctttgcagcttcgttt-3' for Igf1, 5'-gtcgatgttggtgcttctca-3' and 5'-aagcagcactcttccacgat-3' for Igf2 and 5'-cgctgagccagtcagtgtag-3' for 18S. Gapdh and Beta-actin primers were as previously described [72,73].
###end p 75
###begin title 76
Immunohistochemistry
###end title 76
###begin p 77
###xml 833 838 <span type="species:ncbi:9796">horse</span>
###xml 914 918 <span type="species:ncbi:9925">Goat</span>
###xml 1001 1006 <span type="species:ncbi:9796">horse</span>
E12.5 embryos were fixed in pre-cooled Carnoys (60% ethanol, 30% chloroform, and 10% glacial acetic acid) for 25 min at 4degreesC, then washed three times for 2 min in 96% ethanol, then 100% ethanol for 2 and 7 min, respectively. Embryos were then cleared in 1:1 ethanol/chloroform (V/V) for 10 min and chloroform for 10 min, then 1hr. Embryos were then impregnated in three changes of 56-58degreesC melting point paraffin wax (Sigma-Aldrich) for 30 min each at 65degreesC and embedded. 10 mum sections were dewaxed in xylene and rehydrated through a series of graded ethanol. Washes in PBS with 0.02% Tween 20 were carried out between each subsequent step. Endogenous peroxidases were quenched by incubation in 3% hydrogen peroxide in water for 5 min, then 0.5% hydrogen peroxide in methanol for 1 hr. Sections were blocked in 2.5% horse blocking serum (RTU VECTASTAIN universal quick kit, Vector Labs) for 1 hr. Goat anti-CDKN1C primary antibody M-20 (SC-1039, Santa Cruz) was diluted 1/50 in 0.04% horse blocking serum and incubated at 4degreesC overnight. Primary antibody was removed and secondary antibody and streptavidin/peroxidase steps were carried out as per manufacturers instructions (RTU VECTASTAIN universal quick kit, Vector Labs). Sigma Fast DAB substrate system was used to visualise staining. Sections were counterstained with Gills III hematoxylin for 1 min then destained for 1 min with acid/alcohol solution (0.5% HCl, 70% ethanol). Sections were dehydrated through a series of graded ethanol and washed in xylene before mounting with DPX mounting medium.
###end p 77
###begin title 78
Abbreviations
###end title 78
###begin p 79
BAC Bacterial Artificial Chromosome
###end p 79
###begin p 80
BWS Beckwith-Weidemann Syndrome
###end p 80
###begin p 81
###xml 5 9 2 6 <italic xmlns:xlink="http://www.w3.org/1999/xlink">geo </italic>
###xml 14 36 8 30 <italic xmlns:xlink="http://www.w3.org/1999/xlink">galactosidase-neomycin</italic>
beta-geo beta-galactosidase-neomycin
###end p 81
###begin p 82
IC Imprinting Centre
###end p 82
###begin p 83
PCR Polymerase Chain Reaction
###end p 83
###begin p 84
RT Reverse transcriptase
###end p 84
###begin p 85
###xml 4 9 <span type="species:ncbi:4932">Yeast</span>
YAC Yeast Artificial Chromosome
###end p 85
###begin title 86
Authors' contributions
###end title 86
###begin p 87
###xml 131 138 131 138 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cdkn1c </italic>
RMJ was the major contributor to conception and design, acquisition of data, analysis and interpretation of data and generated the Cdkn1c transgenic lines in the study and drafted the manuscript. MAS contributed to conception and design. SCB generated the control transgenic line and participated in the initial characterisations. SCA was involved in the acquisition of data, analysis and interpretation of data. MDW designed and implemented qRT-PCR studies while SJT dissected animals for data and managed the transgenic colonies.
###end p 87
###begin p 88
All authors read and approved the final manuscript.
###end p 88
###begin title 89
Acknowledgements
###end title 89
###begin p 90
This work was supported by The Wellcome Trust grant 074851. MDW is a BBSRC PhD student and SJT is a MRC PhD student. The authors would like to thank Dr Andrew Ward and Dr Nick Allen for their insightful comments.
###end p 90
###begin article-title 91
Imprinting and the initiation of gene silencing in the germ line
###end article-title 91
###begin article-title 92
###xml 27 32 <span type="species:ncbi:10090">mouse</span>
Parental imprinting of the mouse insulin-like growth factor II gene
###end article-title 92
###begin article-title 93
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Genetics of mouse growth
###end article-title 93
###begin article-title 94
###xml 31 36 <span type="species:ncbi:10090">mouse</span>
Genomic imprinting of Mash2, a mouse gene required for trophoblast development.
###end article-title 94
###begin article-title 95
###xml 24 28 <span type="species:ncbi:10090">mice</span>
Placental overgrowth in mice lacking the imprinted gene Ipl
###end article-title 95
###begin article-title 96
Abnormal maternal behaviour and growth retardation associated with loss of the imprinted gene Mest [see comments]
###end article-title 96
###begin article-title 97
Regulation of maternal behavior and offspring growth by paternally expressed Peg3
###end article-title 97
###begin article-title 98
Disruption of the imprinted Grb10 gene leads to disproportionate overgrowth by an Igf2-independent mechanism
###end article-title 98
###begin article-title 99
Regulation of growth and metabolism by imprinted genes
###end article-title 99
###begin article-title 100
###xml 34 39 <span type="species:ncbi:9606">human</span>
Imprinted genes and their role in human fetal growth
###end article-title 100
###begin article-title 101
Imprinted genes in placental growth and obstetric disorders
###end article-title 101
###begin article-title 102
Genomic imprinting and the strange case of the insulin-like growth factor II receptor
###end article-title 102
###begin article-title 103
Genomic imprinting in mammalian development: a parental tug-of-war
###end article-title 103
###begin article-title 104
Mammalian Genetics Unit
###end article-title 104
###begin article-title 105
Imprinted Nesp55 influences behavioral reactivity to novel environments
###end article-title 105
###begin article-title 106
The imprinted signaling protein XL alpha s is required for postnatal adaptation to feeding
###end article-title 106
###begin article-title 107
###xml 86 90 <span type="species:ncbi:10090">mice</span>
Neurobehavioral and electroencephalographic abnormalities in Ube3a maternal-deficient mice
###end article-title 107
###begin article-title 108
A role for the Ras signalling pathway in synaptic transmission and long- term memory
###end article-title 108
###begin article-title 109
###xml 98 102 <span type="species:ncbi:10090">mice</span>
Xlr3b is a new imprinted candidate for X-linked parent-of-origin effects on cognitive function in mice
###end article-title 109
###begin article-title 110
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Differential activity of maternally and paternally derived chromosome regions in mice
###end article-title 110
###begin article-title 111
###xml 47 52 <span type="species:ncbi:10090">mouse</span>
Interactions between imprinting effects in the mouse
###end article-title 111
###begin article-title 112
###xml 69 74 <span type="species:ncbi:10090">mouse</span>
Molecular and embryological investigations of parental imprinting on mouse chromosome 7.
###end article-title 112
###begin article-title 113
###xml 80 84 <span type="species:ncbi:10090">mice</span>
Non-imprinted Igf2r expression decreases growth and rescues the Tme mutation in mice
###end article-title 113
###begin article-title 114
Deletion of the H19 differentially methylated domain results in loss of imprinted expression of H19 and Igf2
###end article-title 114
###begin article-title 115
###xml 53 57 <span type="species:ncbi:10090">mice</span>
Regional loss of imprinting and growth deficiency in mice with a targeted deletion of KvDMR1
###end article-title 115
###begin article-title 116
A gene expression atlas of the central nervous system based on bacterial artificial chromosomes
###end article-title 116
###begin article-title 117
p57KIP2, a structurally distinct member of the p21CIP1 Cdk inhibitor family, is a candidate tumor suppressor gene
###end article-title 117
###begin article-title 118
Cloning of p57KIP2, a cyclin-dependent kinase inhibitor with unique domain structure and tissue distribution
###end article-title 118
###begin article-title 119
###xml 71 76 <span type="species:ncbi:10090">mouse</span>
Genomic imprinting of p57KIP2, a cyclin-dependent kinase inhibitor, in mouse
###end article-title 119
###begin article-title 120
###xml 34 39 <span type="species:ncbi:9606">human</span>
Imprinting of the gene encoding a human cyclin-dependent kinase inhibitor, p57KIP2, on chromosome 11p15
###end article-title 120
###begin article-title 121
###xml 50 54 <span type="species:ncbi:10090">mice</span>
Altered cell differentiation and proliferation in mice lacking p57KIP2 indicates a role in Beckwith-Wiedemann syndrome
###end article-title 121
###begin article-title 122
###xml 104 109 <span type="species:ncbi:10090">mouse</span>
Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development
###end article-title 122
###begin article-title 123
New p57KIP2 mutations in Beckwith-Wiedemann syndrome
###end article-title 123
###begin article-title 124
An imprinted gene p57(KIP2) is mutated in Beckwith-Wiedemann syndrome
###end article-title 124
###begin article-title 125
Low frequency of p57KIP2 mutation in Beckwith-Wiedemann syndrome
###end article-title 125
###begin article-title 126
Coding mutations in p57KIP2 are present in some cases of Beckwith- Wiedemann syndrome but are rare or absent in Wilms tumors
###end article-title 126
###begin article-title 127
Epigenotype-phenotype correlations in beckwith-wiedemann syndrome
###end article-title 127
###begin article-title 128
###xml 94 99 <span type="species:ncbi:10090">mouse</span>
p57(Kip2) regulates progenitor cell proliferation and amacrine interneuron development in the mouse retina
###end article-title 128
###begin article-title 129
p57(Kip2) cooperates with Nurr1 in developing dopamine cells
###end article-title 129
###begin article-title 130
The two-domain hypothesis in Beckwith-Wiedemann syndrome
###end article-title 130
###begin article-title 131
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Oppositely imprinted genes p57(Kip2) and igf2 interact in a mouse model for Beckwith-Wiedemann syndrome
###end article-title 131
###begin article-title 132
The two-domain hypothesis in Beckwith-Wiedemann syndrome: autonomous imprinting of the telomeric domain of the distal chromosome 7 cluster
###end article-title 132
###begin article-title 133
###xml 2 7 <span type="species:ncbi:9606">human</span>
###xml 77 82 <span type="species:ncbi:10090">mouse</span>
A human p57(KIP2) transgene is not activated by passage through the maternal mouse germline
###end article-title 133
###begin article-title 134
###xml 58 63 <span type="species:ncbi:10090">mouse</span>
###xml 111 116 <span type="species:ncbi:9606">human</span>
Distant cis-elements regulate imprinted expression of the mouse p57( Kip2) (Cdkn1c) gene: implications for the human disorder, Beckwith--Wiedemann syndrome
###end article-title 134
###begin article-title 135
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice lacking a CDK inhibitor, p57Kip2, exhibit skeletal abnormalities and growth retardation
###end article-title 135
###begin article-title 136
###xml 51 57 <span type="species:ncbi:9606">humans</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
The IPL gene on chromosome 11p15.5 is imprinted in humans and mice and is similar to TDAG51, implicated in Fas expression and apoptosis
###end article-title 136
###begin article-title 137
IMPT1, an imprinted gene similar to polyspecific transporter and multi-drug resistance genes
###end article-title 137
###begin article-title 138
Placental growth retardation due to loss of imprinting of Phlda2
###end article-title 138
###begin article-title 139
Placental-specific IGF-II is a major modulator of placental and fetal growth
###end article-title 139
###begin article-title 140
###xml 104 107 <span type="species:ncbi:10116">rat</span>
Cellular pattern of type-I insulin-like growth factor receptor gene expression during maturation of the rat brain: comparison with insulin-like growth factors I and II
###end article-title 140
###begin article-title 141
The role of the insulin-like growth factors in the central nervous system
###end article-title 141
###begin article-title 142
###xml 51 55 <span type="species:ncbi:10090">mice</span>
Phenotypic alterations in insulin-deficient mutant mice
###end article-title 142
###begin article-title 143
###xml 0 4 <span type="species:ncbi:10090">Mice</span>
Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r)
###end article-title 143
###begin article-title 144
###xml 49 53 <span type="species:ncbi:10090">mice</span>
IGF-I is required for normal embryonic growth in mice
###end article-title 144
###begin article-title 145
Loss of the maternal H19 gene induces changes in Igf2 methylation in both cis and trans
###end article-title 145
###begin article-title 146
The centromeric 11p15 imprinting centre is also involved in Silver-Russell syndrome
###end article-title 146
###begin article-title 147
Preterm delivery, low birthweight and small-for-gestational-age in liveborn singleton babies resulting from in-vitro fertilization
###end article-title 147
###begin article-title 148
###xml 0 8 <span type="species:ncbi:9606">Children</span>
Children after in vitro fertilization. An overview of the literature
###end article-title 148
###begin article-title 149
###xml 33 40 <span type="species:ncbi:9606">infants</span>
Low and very low birth weight in infants conceived with use of assisted reproductive technology
###end article-title 149
###begin article-title 150
Association of in vitro fertilization with Beckwith-Wiedemann syndrome and epigenetic alterations of LIT1 and H19
###end article-title 150
###begin article-title 151
Epigenetic risks related to assisted reproductive technologies: epigenetics, imprinting, ART and icebergs?
###end article-title 151
###begin article-title 152
Beckwith-Wiedemann syndrome and assisted reproduction technology (ART)
###end article-title 152
###begin article-title 153
Imprinting and assisted reproductive technology
###end article-title 153
###begin article-title 154
Allelic expression of IGF2 in marsupials and birds
###end article-title 154
###begin article-title 155
Monotreme IGF2 expression and ancestral origin of genomic imprinting
###end article-title 155
###begin article-title 156
Genomic imprinting, mammalian evolution, and the mystery of egg-laying mammals
###end article-title 156
###begin article-title 157
###xml 72 86 <span type="species:ncbi:9315">tammar wallaby</span>
Genomic imprinting of IGF2, p57(KIP2) and PEG1/MEST in a marsupial, the tammar wallaby
###end article-title 157
###begin article-title 158
A transgenic approach to studying imprinted genes: Modified BACs and PACs
###end article-title 158
###begin article-title 159
Imprinted expression of neuronatin from modified BAC transgenes reveals regulation by distinct and distant enhancers
###end article-title 159
###begin article-title 160
Primer 3 website
###end article-title 160
###begin article-title 161
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Disruption of imprinting in cloned mouse fetuses from embryonic stem cells
###end article-title 161
###begin article-title 162
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
Exposure of mouse preimplantation embryos to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) alters the methylation status of imprinted genes H19 and Igf2
###end article-title 162

